Clinical Trials Innovation Prize

Producing a breakthrough that doubles the accrual rate of clinical trials in the diagnosis and treatment of cancer. Read Overview...
Total Prize Amount
$150,000

The Previous Phase

Ideation Phase (Closed)
Overview

 

Introduction

 

Each year, in honor of World Cancer Day, the Bonnie J. Addario Lung Cancer Foundation (ALCF) launches a unique, international crowdsourcing challenge that leverages the power of the crowd to solve problems plaguing the oncology clinical medicine space.

We want to work with innovative, out-of-the-box thinkers and innovators who are passionate about changing the lives of thousands of people- cancer patients today, and patients of tomorrow- regardless of whether they have any direct healthcare experience.

For 2016 World Cancer Day, we want YOU to join us and #BeTheSolution!

 

The What?

On February 4, 2016 are launching the second phase of the Clinical Trial Innovation Prize, an international two-part, $180,000 crowdsourcing challenge that seeks to identify innovative ways to increase cancer patient enrollment in clinical trials.

Goal: The goal of the challenge is to produce breakthroughs that will increase the patient accrual rate to oncology clinical trials. ALCF is specifically looking to: 

  1. Identify prototypes of solutions that reduce a barrier to participation in clinical trials
  2. Select the best solution to be scaled in partnership with the Bonnie J. Addario Lung Cancer Foundation
  • Ideation Challenge: 47 Competitors from 18 countries from all around the world submitted creative and novel ideas to double the accrual rate of cancer clinical trials, and three teams won prizes totaling $30,000 USD. Congratulations to HelynxMatt Gerber, and Noah Craft, the winners of the first phase of the challenge!  
  • Implementation/Proof of Concept Challenge: Register now, enter your idea and plans for implementation for a chance to win prizes totaling $150,000 USD when you provide proof that your ideas have indeed resulted in an increase in participation in cancer clinical trials.

 

The Why?

Cancer is one of the leading causes of deaths worldwide! Cancer cases worldwide are forecast to rise by 75% and reach close to 25 million over next two decades

 

We need better ways to prevent, detect, screen and treat cancer, and we need them now!

The most reliable and the only accepted scientific method to take exciting discoveries from the lab bench to the bedside is testing the safety and efficacy of these new interventions in clinical trials -- research studies that test new methods of prevention, detection, screening and treatment of cancer.

 

 

Unfortunately, most cancer patients don't know that clinical trials may be a treatment option, and there are several myths and misconceptions associated with clinical trials!

 

 

Due to a variety of factors such as myths and misconceptions; geographic, language and socio-economic barriers; lack of awareness among patients and physicians; procedural inefficiences (such as complexities in enrolling in the trial itself, the informed consent process), etc., several trials are halted prematurely as they FAIL to enroll enough patients, thereby wasting precious research dollars and impeding the development of life-saving cancer diagnostics and treatments.

 

 

On average, 3-5% of all adult cancer patients participate in clinical trials!

Participation is even lower among particular groups, including people who are racial and ethnic minorities, over 65, lower income, and living in rural areas. As an example, ~53% of new cancer diagnoses are in people 65 or older, however, this age demographic accounts for a measly 33% of clinical trial participants. Compare this to pediatric clinical trials!

 

So, what can we do to increase patient accrual to oncology clinical trials?

We need YOU to help us identify breakthroughs that will allow clinical trials to accrue patients quickly, so that we can get life-saving diagnostics and treatments to patients, faster!

Resgister now and submit your breakthrough solution to this problem! #BeTheSOLUTION! 

 

Why an Innovation Prize/ Crowdsourcing Challenge?

We know that amazing ideas can come from anywhere! Despite 50 years of trying, members of the medical community have been unable to develop transformational solutions to these intractable problems.

So, we are trying something different! We want YOU to help us find cool ways to increase the accrual rate of cancer clinical trials!

We believe an Innovation Prize could have a profound impact on improving cancer care, too. Help us make it happen!

Register on this page and participate in this challenge to make an impact on the lives of cancer patients, and for the chance to win $150,000!

 

Contact Us: 

  • Have questions? Send us an email at, and we'll get back to you rightaway! 
  • If you have a solution that you believe could increase accrual rates but don’t know how to implement it, email us (). We will support you to determine how best to test the solution. 
  • We know the next breakthrough can come from anywhere and we are committed to finding a way to increase patient accrual to clinical trials!
Updates (11)
Forum (6)
Timeline
Guidelines
Community
Entries
Resources
FAQ
Activity feed
show all
Almac Group posted tweet
April 24, 2017, 3:56 a.m. PDT
Four things you need to know about Temperature Management: https://t.co/egK4TKUrhy #clinicaltrials https://t.co/JBvtTk7MWx
Idem Translations posted tweet
April 24, 2017, 3:56 a.m. PDT
Countdwn to the #ACRP conf #Seattle is upon us. Global #ClinicalTrials on the horizon? Ping us to discuss #translations @ACRPDC @ACRP_Canada
IQPC posted tweet
April 24, 2017, 3:56 a.m. PDT
RT AlmacGroup: Four things you need to know about Temperature Management: https://t.co/x05UcNp9LE #clinicaltrials https://t.co/howQBWmW2I
Dr. Liz Samander posted tweet
April 24, 2017, 3:56 a.m. PDT
Recruitment begins for world’s first ovarian cancer vaccine trial #ovariancancer #clinicaltrials #vaccine #UConn https://t.co/5D62L1Rlgi
TrialsTracker posted tweet
April 24, 2017, 3:56 a.m. PDT
Yonsei University hasn't reported results for 139 #clinicaltrials https://t.co/lNBisbX2Fs #AllTrials https://t.co/MckifwHZo2
Clinical Trials News posted tweet
April 24, 2017, 3:05 a.m. PDT
#clinicaltrials news Pivotal Phase III Study Underscores Efficacy Of Zavicefta ceftazidimeavibactam For Treatme... https://t.co/gyiUd2LPdD
NorthWest EHealth posted tweet
April 24, 2017, 3:05 a.m. PDT
On Thursday we will be speaking at the #Digital, #Data and #Technology: Disrupting #ClinicalTrials #OHT17 in #London @oht_uk
ICON Plc posted tweet
April 24, 2017, 2:14 a.m. PDT
Vicki Anastasi shares insights on how to avoid common pitfalls in #clinicaltrials at @MedTechStrat #Dublin2017… https://t.co/jsmCwtfmQ2
TrialsTracker posted tweet
April 24, 2017, 2:14 a.m. PDT
.@AstraZeneca You've conducted 408 #clinicaltrials but not reported the results of 68 (16.7%)… https://t.co/h0FIDY41TW
One HealthTech posted tweet
April 24, 2017, 2:14 a.m. PDT
Excited to talk #Data #Digital & #Tech disrupting #ClinicalTrials this week! Full refund on attendance to event >… https://t.co/CISdwhlWf6